Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination of Indinavir, Ritonavir, ddI, and d4T in Experienced HIV Patients
NCT00006397Phase 3Unknown
- Sponsor
- PPD
- Start
- Aug 2000
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, open-label, single-arm trial of indinavir, ritonavir, didanosine and stavudine in human immunodeficiency virus infection (HIV), sponsored by PPD. Primary endpoints: Safety of the combination regimen and Efficacy of the combination regimen. Status: unknown.
02
Drugs
indinavirritonavirdidanosinestavudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00006397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006397.